Cargando…
Tumor heterogeneity as a rationale for a multi-epitope approach in an autologous renal cell cancer tumor vaccine
PURPOSE: An autologous tumor vaccine already used successfully in the immune therapy of renal cell carcinoma was investigated in detail. The evaluation of potential tumor markers should allow for the assessment of potency according to pharmaceutical regulations. METHODS: A panel of 36 tumor-associat...
Autores principales: | Wittke, Stefan, Baxmann, Susann, Fahlenkamp, Dirk, Kiessig, Stephan T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743638/ https://www.ncbi.nlm.nih.gov/pubmed/26889089 http://dx.doi.org/10.2147/OTT.S92182 |
Ejemplares similares
-
Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of α-Gal Glycolipids that Induce Anti-Gal/α-Gal Epitope Interaction
por: Galili, Uri
Publicado: (2011) -
Challenges in the development of an autologous heat shock protein based anti-tumor vaccine
por: Reitsma, Dirk J., et al.
Publicado: (2012) -
Editorial: Multi-omics analysis in tumor microenvironment and tumor heterogeneity
por: Shi, Yuxin, et al.
Publicado: (2023) -
Autologous tumor lysate-loaded dendritic cell vaccination combined with Sunitinib for metastatic renal cell carcinoma
por: Kakimi, Kazuhiro, et al.
Publicado: (2014) -
Large‐scale production, purification, and function of a tumor multi‐epitope vaccine: Peptibody with bFGF/VEGFA
por: Zhang, Ligang, et al.
Publicado: (2020)